Recent studies have showed that CXCL5 and its receptors are implicated in congestive heart failure and ischemic stroke, making CXCL5 a candidate gene for potential future therapy strategies in cardiovascular diseases [28–30]. Here, CXCL5 is linked to cardiovascular disorder.